Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.654, 2012-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Costs of Inflammatory Bowel Disease in Germany
By Stark Renee
PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. :
Access to resources
Recommend
Inflammatory bowel disease: not all costs are equal in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. :
Costs of inflammatory bowel disease in the US substantial
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :